This Article Full Text Full Text (PDF) Submit a related Letter to the Editor Purchase Article View Shopping Cart Alert me when this article is cited Alert me when eLetters are posted Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Copyright Permission Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Stewart, D. R. Articles by Seppala, M. Search for Related Content PubMed PubMed Citation Articles by Stewart, D. R. Articles by Seppala, M.

The Role of Relaxin in Glycodelin Secretion¹

Division of Reproductive Biology and Medicine, Department of Obstetrics and Gynecology (D.R.S., S.T.N., J.W.O.), Institute of Toxicology and Environmental Health, University of California (D.R.S., J.W.O., B.L.L.), Davis, California 95616; Connective Therapeutics, Inc. (M.S.E., M.E.E., E.P.A.), Palo Alto, California 94303; Department of Obstetrics and Gynecology, Helsinki University Central Hospital (M.S.), Helsinki, Finland

Address all correspondence and requests for reprints to: Dr. Dennis R. Stewart, Med:Reproductive Biology, Suber House, University of California, Davis, California 95616.

Glycodelin is a glycoprotein named for its unique carbohydrate structure. Glycodelin is produced by the secretory endometrium during the late luteal phase and returns to baseline during menses of the ensuing cycle, whereas in conceptive cycles it rapidly increases. Although progesterone and possibly estradiol are required for glycodelin production, they are not directly involved in the synthesis and release of this protein. Their role may be development of the endometrial secretory glandular elements, whereas other factors are required to initiate and maintain glycodelin secretion. The pattern of relaxin secretion during the luteal phase and early pregnancy is similar to that of glycodelin, but their profiles have not been determined simultaneously.

To investigate the relationship of relaxin and glycodelin, two studies were conducted. In the first study, relaxin, glycodelin, and ovarian steroids were measured in daily serum samples from nonconceptive and conceptive natural cycles. Profiles of relaxin and glycodelin were closely associated, with the onset of relaxin preceding glycodelin secretion by 1–2 days in nonconceptive cycles, and the pregnancy-associated increases in each hormone differing by about 2 days. The second study tested the hypothesis that relaxin stimulates glycodelin secretion. Samples were obtained from patients injected with human relaxin for 28 days. In subjects demonstrating ovarian cyclicity, glycodelin secretion was elevated, but it was not detected in subjects without ovarian cyclicity or in placebo-treated control subjects.

This study reveals a close temporal and quantitative relationship between relaxin and glycodelin profiles in the late luteal phase and early pregnancy. It also demonstrates that relaxin administration can stimulate glycodelin production from a developed endometrium. This is the first report of a nonsteroidal ovarian factor that controls glycodelin secretion, and these results suggest a function for relaxin during early pregnancy. Glycodelin is a potent inhibitor of sperm zona pellucida binding by virtue of its extensive carbohydrate structure, but it is normally at a nadir in the periovulatory period. The data demonstrate that relaxin can stimulate glycodelin secretion throughout the menstrual cycle, including the periovulatory period, when relaxin-induced glycodelin secretion could have a contraceptive effect.

This article has been cited by other articles:

				M. Seppala, H. Koistinen, R. Koistinen, P.C.N. Chiu, and W.S.B. Yeung Glycosylation related actions of glycodelin: gamete, cumulus cell, immune cell and clinical associations Hum. Reprod. Update, May 1, 2007; 13(3): 275 - 287. [Abstract] [Full Text] [PDF]

				O. D. Sherwood Relaxin's Physiological Roles and Other Diverse Actions Endocr. Rev., April 1, 2004; 25(2): 205 - 234. [Abstract] [Full Text] [PDF]

				L. T. Goldsmith, G. Weiss, S. Palejwala, T. M. Plant, A. Wojtczuk, W. C. Lambert, N. Ammur, D. Heller, J. H. Skurnick, D. Edwards, et al. Relaxin regulation of endometrial structure and function in the rhesus monkey PNAS, March 30, 2004; 101(13): 4685 - 4689. [Abstract] [Full Text] [PDF]

				O. Bartsch, B. Bartlick, and R. Ivell Phosphodiesterase 4 Inhibition Synergizes with Relaxin Signaling to Promote Decidualization of Human Endometrial Stromal Cells J. Clin. Endocrinol. Metab., January 1, 2004; 89(1): 324 - 334. [Abstract] [Full Text] [PDF]

				M. Seppala, R. N. Taylor, H. Koistinen, R. Koistinen, and E. Milgrom Glycodelin: A Major Lipocalin Protein of the Reproductive Axis with Diverse Actions in Cell Recognition and Differentiation Endocr. Rev., August 1, 2002; 23(4): 401 - 430. [Abstract] [Full Text] [PDF]

				J.Y.M. Tse, P.C.N. Chiu, K.F. Lee, M. Seppala, H. Koistinen, R. Koistinen, Y.Q. Yao, and W.S.B. Yeung The synthesis and fate of glycodelin in human ovary during folliculogenesis Mol. Hum. Reprod., February 1, 2002; 8(2): 142 - 148. [Abstract] [Full Text] [PDF]

				J. T. Arnold, B. A. Lessey, M. Seppala, and D. G. Kaufman Effect of Normal Endometrial Stroma on Growth and Differentiation in Ishikawa Endometrial Adenocarcinoma Cells Cancer Res., January 1, 2002; 62(1): 79 - 88. [Abstract] [Full Text] [PDF]

				S. Banaszak, A. Brudney, K. Donnelly, D. Chai, K. Chwalisz, and A. T. Fazleabas Modulation of the Action of Chorionic Gonadotropin in the Baboon (Papio anubis) Uterus by a Progesterone Receptor Antagonist (ZK 137.316) Biol Reprod, September 1, 2000; 63(3): 820 - 825. [Abstract] [Full Text]

				L. Tseng, H. H. Zhu, J. Mazella, H. Koistinen, and M. Seppala Relaxin stimulates glycodelin mRNA and protein concentrations in human endometrial glandular epithelial cells Mol. Hum. Reprod., April 1, 1999; 5(4): 372 - 375. [Abstract] [Full Text] [PDF]

				A. T. Fazleabas, K. M. Donnelly, S. Srinivasan, J. D. Fortman, and J. B. Miller Modulation of the baboon (Papio anubis) uterine endometrium by chorionic gonadotrophin during the period of uterine receptivity PNAS, March 2, 1999; 96(5): 2543 - 2548. [Abstract] [Full Text] [PDF]

				E. N. Unemori, M. E. Erikson, S. E. Rocco, K. M. Sutherland, D. A. Parsell, J. Mak, and B. H. Grove Relaxin stimulates expression of vascular endothelial growth factor in normal human endometrial cells in vitro and is associated with menometrorrhagia in women Hum. Reprod., March 1, 1999; 14(3): 800 - 806. [Abstract] [Full Text] [PDF]

				D. R. Stewart and C. A. VandeVoort Relaxin secretion by human granulosa cell culture is predictive of in-vitro fertilization–embryo transfer success Hum. Reprod., February 1, 1999; 14(2): 338 - 344. [Abstract] [Full Text] [PDF]

				R. N. Taylor, J.-F. Savouret, C. Vaisse, J.-L. Vigne, I. Ryan, D. Hornung, M. Seppälä, and E. Milgrom Promegestone (R5020) and Mifepristone (RU486) Both Function as Progestational Agonists of Human Glycodelin Gene Expression in Isolated Human Epithelial Cells J. Clin. Endocrinol. Metab., November 1, 1998; 83(11): 4006 - 4012. [Abstract] [Full Text]

				H. M. Hausermann, K. M. Donnelly, S. C. Bell, H. G. Verhage, and A. T. Fazleabas Regulation of the Glycosylated {beta}-Lactoglobulin Homolog, Glycodelin [Placental Protein 14:(PP14)] in the Baboon (Papio anubis) Uterus J. Clin. Endocrinol. Metab., April 1, 1998; 83(4): 1226 - 1233. [Abstract] [Full Text]

				J.-L. Vigne, D. Hornung, M. D. Mueller, and R. N. Taylor Purification and Characterization of an Immunomodulatory Endometrial Protein, Glycodelin J. Biol. Chem., May 11, 2001; 276(20): 17101 - 17105. [Abstract] [Full Text] [PDF]